In high - income countries, 10 years of
oral contraceptive use reduces the risk of developing endometrial cancer before age 75 from 2.3 to 1.3 cases per 100 users.
The findings reveal that every 5 years of
oral contraceptive use reduces the risk of endometrial cancer by about a quarter.
Not exact matches
According to study author Dr Naomi Allen, also from the University of Oxford, UK, «The existing evidence suggests that medium - to - long - term
use of
oral contraceptives (ie, for 5 years or longer) results in substantially
reduced risk of endometrial cancer.
A 2013 research review published in Obstetrics and Gynecology examined the results of 55 studies and found that for women with average risk,
using oral contraceptives reduced lifetime risk of ovarian cancer by 40 to 50 %.